Breckenridge signs multiproduct agreement with WeldingThe agreement currently covers one delayed-release tablet product and two injectable products, which collectively had sales of $300 million for the year ended April 2021. Amneal launches 1st generic of IntelenceIntelence had a U.S. market size of roughly $99.4 million for the year ended April 2021, according to IQVIA data. FDA clears Cipla’s generic Brovana Brovana had a market value of approximately $438 million for the 12-month period ending April 2021, according to IQVIA. Lupin debuts generic Truvada Emtricitabine and tenofovir disoproxil fumarate tablets had a market value of $2.1 billion, according to March 2021 IQVIA data. Upsher-Smith launches generic Absorica The isotretinoin capsule had a market value of approximately $156 million for the 12 months ended April 2021, according to IQVIA. Hikma releases generic Banzel The product is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome. Cipla obtains FDA OK for generic Brovana Brovana had a market value of approximately $438 million for the 12-month period ending April 2021, according to IQVIA. Hikma intros doxycycline for injection Doxycycline for injection had a market value of approximately $43 million in the 12 months ended April 2021, according to IQVIA. Glenmark obtains FDA tentative nod for generic Ofev Glenmark has received tentative approval from the Food and Drug Administration for nintedanib capsules in dosage strengths of 100 mg and 150 mg. Alembic intros generic ProAmatine Alembic's generic ProAmatine provides a treatment for symptomatic orthostatic hypotension. First Previous 105 106 107 108 109 Next Last